Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

[New developments in treatment of non-small cell lung cancer]

N Reinmuth1, A Gröschel, M Reck

  • 1LungenClinic, Onkologischer Schwerpunkt, Großhansdorf.

Pneumologie (Stuttgart, Germany)
|November 8, 2013
PubMed

Insights

New developments in non-small cell lung cancer treatment were discussed at the American Society of Clinical Oncology (ASCO) annual meeting. This article highlights key findings and novel therapeutic approaches presented.

Area of Science:

  • Oncology
  • Clinical Research
  • Therapeutics

Context:

  • The annual meeting of the American Society of Clinical Oncology (ASCO) is a premier event for presenting cutting-edge cancer research.
  • Discussions at ASCO often shape the future direction of cancer treatment and clinical practice.

Purpose:

  • To summarize novel findings and therapeutic strategies in non-small cell lung cancer (NSCLC) presented at the recent ASCO meeting.
  • To provide an overview of new hypotheses and clinical studies relevant to NSCLC treatment.

Summary:

  • Several new hypotheses, therapy approaches, and clinical studies concerning non-small cell lung cancer were presented and discussed at the ASCO annual meeting.
  • Key advancements and emerging trends in NSCLC treatment were a significant focus of the discussions.

Impact:

  • This summary offers insights into the latest progress in non-small cell lung cancer research.
  • It informs clinicians and researchers about potential new avenues for NSCLC therapy and patient care.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

565
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

9.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K